Dear Nelson and Friends, I read with interest the attached excellent review of treatment strategies for PRN Notebook by Dr's Charles Farthing and Athe...
I apologize to those of you who will not understand some terms ... My experience with MK 518 and Prezista..and thoughts about TNX 355 I have been positive...
14th Conference on Retroviruses and Opportunistic Infections: An Interview With Roy Gulick Coverage provided by Bonnie Goldman February 27, 2007 _Listen _ ...
From Medscape: CROI 2007 - New Antiretrovirals/New Drug Classes Editor's Note: Dr. Mark Wainberg, Director, McGill University AIDS Centre, McGill University,...
Summary and Comment Who Will Benefit from CCR5 Inhibitors? More-advanced disease is correlated with a higher probability of mixed viral populations or...
Please read the article written by Enid Vazquez in the latest Positively Aware, one of the main free HIV magazines distributed around the U.S. My comments...
For those of you applying for TMC 125 Expanded Access and who have had NNRTI resistance in the past (resistance to Sustiva or Viramune), read this: I want to...
Hi every one, My name is Michael. I am an artist and my life is typical of all those manic, mental, sexually frustrated artist you should have read about in...
Dear Michael: We've all been where you are at some point in our long struggle with HIV/AIDS. Do you have any support groups in Tennessee? Find an upbeat one....
Hello, Michael, My name is Joe, and like you, I am an artist, or at least like to think that I am, and I started using Fuzeon on 12/2/05. You mention hard...
Dear Michael, DON'T GIVE UP, DON'T EVER GIVE UP!! You have not survived this long for these years to be for naught. I have had too many friends that didn't...
24 March 2007 I wanted to acknowledge those whom responded to my post on the fuzeon group. Thank you for concern and taking the time to post. Just to let you...
Title: Latest Update on HIV Research Seminar date : April 19, Thursday Time: 6:00 pm til 8:30 pm Free dinner and door prizes Speakers: Shannon Schrader MD...
(http://medscape.com/) _www.medscape.com_ (http://www.medscape.com/) To Print: Click your browser's PRINT button. NOTE: To view the article with Web...
_Aidsmap | Is there any clinical benefit to staying on a failing regimen?_ (http://www.aidsmap.com/en/news/5103509E-A2E2-4B6B-8CCC-343245F1C3AD.asp) Regards, ...
We only have 12 seats left Title: Latest Update on HIV Research Integrase inhibitors CCR5 inhibitor Maraviroc Metabolic complications and lipodystrophy Anal...
From Clinical Care Options Case The patient is a 44-year-old male with HIV, diagnosed in 1994 when he presented with oral hairy leukoplakia, thrush, and...
I hope some of you can still join us! This is the 10 th anniversary. This is the most economical rate found for a cruise of this type. There will be three...
Read on Regards, Nelson Vergel powerusa dot org "I learned that...no one is perfect but most people are good; that people can't be judged only by the worst...
To be approved soon: Maraviroc (ccr5 inhibitor), new name: Celsentri To be approved in fall 2007: Raltegravir (integrase inhibitor- old name mk518) , new...
State-of-the-Art: HIV Therapy for the Treatment Experienced An Interview With Eric Daar, M.D., and Positively Aware Editor Jeff Berry from _thebody.com_...
this drug will be approved next week.... NATAP http://natap.org/ _______________________________________________ Maraviroc Analysis Highlights Difficulties in...
In a message dated 6/11/2007 7:19:27 A.M. Central Daylight Time, nataphcvhiv@... writes: 3 New HIV Drugs 'Transform Prognosis' for Salvage-integrase,...
"Tipranavir (Aptivus) before darunavir (Prezista) increases susceptibility to darunavir for the circulating virus population. The impact of archived ...
FDA grants speedy review for new class of HIV drug Wed Jun 27, 2007 1:25PM EDT NEW YORK (Reuters Health) - U.S. regulators will review Isentress, an ...
Efficacy and Tolerance of the Switch From Enfuvirtine to Raltegravir in Antiretroviral Therapy Regimen in HIV Patients With Undetectable Viral Load (EASIER) ...
Having problems with message search?
Fill out this form to ensure your group is one of the first to be migrated to the new message search system.
